Luke A. Miles

1.4k total citations
32 papers, 1.1k citations indexed

About

Luke A. Miles is a scholar working on Physiology, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Luke A. Miles has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 13 papers in Molecular Biology and 8 papers in Computational Theory and Mathematics. Recurrent topics in Luke A. Miles's work include Alzheimer's disease research and treatments (17 papers), Computational Drug Discovery Methods (8 papers) and Advanced Chemical Physics Studies (7 papers). Luke A. Miles is often cited by papers focused on Alzheimer's disease research and treatments (17 papers), Computational Drug Discovery Methods (8 papers) and Advanced Chemical Physics Studies (7 papers). Luke A. Miles collaborates with scholars based in Australia, United States and Germany. Luke A. Miles's co-authors include Michael W. Parker, Gabriela A. N. Crespi, Neville L. Arthur, Kevin J. Barnham, Larissa Doughty, Colin L. Masters, Roberto Cappai, S.J. Hermans, Craig J. Morton and Deborah J. Tew and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Luke A. Miles

32 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luke A. Miles Australia 19 607 434 189 160 140 32 1.1k
Steven Lynham United Kingdom 18 449 0.7× 753 1.7× 56 0.3× 47 0.3× 103 0.7× 49 1.4k
James F. LeBlanc United States 14 353 0.6× 665 1.5× 34 0.2× 75 0.5× 50 0.4× 20 1.2k
David A. Middleton United Kingdom 26 505 0.8× 1.1k 2.5× 64 0.3× 58 0.4× 37 0.3× 102 2.0k
Jeffrey Hanson United States 17 356 0.6× 826 1.9× 39 0.2× 56 0.3× 212 1.5× 24 1.4k
Guowei Yin China 17 321 0.5× 854 2.0× 47 0.2× 57 0.4× 124 0.9× 35 1.5k
Stefan W. Vetter United States 18 186 0.3× 1.1k 2.5× 62 0.3× 40 0.3× 44 0.3× 45 1.6k
Steven A. Rich United States 10 429 0.7× 624 1.4× 24 0.1× 37 0.2× 85 0.6× 20 1.3k
Francesco Ravotti Switzerland 7 549 0.9× 564 1.3× 123 0.7× 64 0.4× 25 0.2× 9 905
Christian Haupt Germany 17 513 0.8× 757 1.7× 66 0.3× 30 0.2× 29 0.2× 42 1.0k
Young‐Sang Jung South Korea 16 463 0.8× 924 2.1× 42 0.2× 27 0.2× 63 0.5× 25 1.6k

Countries citing papers authored by Luke A. Miles

Since Specialization
Citations

This map shows the geographic impact of Luke A. Miles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke A. Miles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke A. Miles more than expected).

Fields of papers citing papers by Luke A. Miles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luke A. Miles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke A. Miles. The network helps show where Luke A. Miles may publish in the future.

Co-authorship network of co-authors of Luke A. Miles

This figure shows the co-authorship network connecting the top 25 collaborators of Luke A. Miles. A scholar is included among the top collaborators of Luke A. Miles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke A. Miles. Luke A. Miles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morgan, Katherine A., Michael de Veer, Luke A. Miles, et al.. (2023). Pre-targeting amyloid-β with antibodies for potential molecular imaging of Alzheimer's disease. Chemical Communications. 59(16). 2243–2246. 6 indexed citations
2.
Bu, Xian‐Le, Pu‐Yang Sun, Dong‐Yu Fan, et al.. (2022). Associations of plasma soluble CD22 levels with brain amyloid burden and cognitive decline in Alzheimer’s disease. Science Advances. 8(13). eabm5667–eabm5667. 17 indexed citations
3.
Li, Yihan, Simon M. Laws, Luke A. Miles, et al.. (2021). Genomics of Alzheimer’s disease implicates the innate and adaptive immune systems. Cellular and Molecular Life Sciences. 78(23). 7397–7426. 49 indexed citations
4.
Miles, Luke A., S.J. Hermans, Gabriela A. N. Crespi, et al.. (2019). Small Molecule Binding to Alzheimer Risk Factor CD33 Promotes Aβ Phagocytosis. iScience. 19. 110–118. 64 indexed citations
5.
Portelius, Erik, Niklas Mattsson, Josef Pannee, et al.. (2017). Ex vivo 18O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway. Molecular Neurodegeneration. 12(1). 18–18. 34 indexed citations
6.
Braig, David, Tracy L. Nero, Xiaowei Wang, et al.. (2017). Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites. Nature Communications. 8(1). 166 indexed citations
7.
Gillinder, Kevin R., Danitza Nébor, Ravi Sachidanandam, et al.. (2016). Promiscuous DNA-binding of a mutant zinc finger protein corrupts the transcriptome and diminishes cell viability. Nucleic Acids Research. 45(3). 1130–1143. 34 indexed citations
8.
Crespi, Gabriela A. N., S.J. Hermans, Michael W. Parker, & Luke A. Miles. (2015). Molecular basis for mid-region amyloid-β capture by leading Alzheimer's disease immunotherapies. Scientific Reports. 5(1). 9649–9649. 77 indexed citations
9.
Crespi, Gabriela A. N., David B. Ascher, Michael W. Parker, & Luke A. Miles. (2014). Crystallization and preliminary X-ray diffraction analysis of the Fab portion of the Alzheimer's disease immunotherapy candidate bapineuzumab complexed with amyloid-β. Acta Crystallographica Section F Structural Biology Communications. 70(3). 374–377. 6 indexed citations
10.
Watt, Andrew D., Gabriela A. N. Crespi, David B. Ascher, et al.. (2014). Do current therapeutic anti-Aβ antibodies for Alzheimer’s disease engage the target?. Acta Neuropathologica. 127(6). 803–810. 44 indexed citations
11.
Miles, Luke A., Gabriela A. N. Crespi, Larissa Doughty, & Michael W. Parker. (2013). Bapineuzumab captures the N-terminus of the Alzheimer's disease amyloid-beta peptide in a helical conformation. Scientific Reports. 3(1). 1302–1302. 103 indexed citations
12.
Parker, L.J., David B. Ascher, Chen Gao, et al.. (2012). Structural approaches to probing metal interaction with proteins. Journal of Inorganic Biochemistry. 115. 138–147. 8 indexed citations
13.
Miles, Luke A., et al.. (2011). An Escherichia coli Cell-Free System for Recombinant Protein Synthesis on a Milligram Scale. Methods in molecular biology. 752. 17–28. 2 indexed citations
14.
Kok, W. Mei, Denis B. Scanlon, John A. Karas, et al.. (2009). Solid-phase synthesis of homodimeric peptides: preparation of covalently-linked dimers of amyloid β peptide. Chemical Communications. 6228–6228. 39 indexed citations
15.
Wun, K.S., Luke A. Miles, Gabriela A. N. Crespi, et al.. (2008). Crystallization and preliminary X-ray diffraction analysis of the Fab fragment of WO2, an antibody specific for the Aβ peptides associated with Alzheimer's disease. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 64(5). 438–441. 9 indexed citations
16.
Miles, Luke A., K.S. Wun, Gabriela A. N. Crespi, et al.. (2008). Amyloid-β–Anti-Amyloid-β Complex Structure Reveals an Extended Conformation in the Immunodominant B-Cell Epitope. Journal of Molecular Biology. 377(1). 181–192. 46 indexed citations
17.
Kong, G.K.-W., Luke A. Miles, Gabriela A. N. Crespi, et al.. (2007). Copper binding to the Alzheimer’s disease amyloid precursor protein. European Biophysics Journal. 37(3). 269–279. 57 indexed citations
18.
Miles, Luke A., Kevin J. Barnham, Mark G. Hinds, et al.. (2002). Structure of a Novel P-superfamily Spasmodic Conotoxin Reveals an Inhibitory Cystine Knot Motif. Journal of Biological Chemistry. 277(45). 43033–43040. 30 indexed citations
19.
Arthur, Neville L. & Luke A. Miles. (1998). Arrhenius parameters for H+(CH3)3GeH and (CH3)2GeH2. Journal of the Chemical Society Faraday Transactions. 94(18). 2741–2744. 3 indexed citations
20.
Arthur, Neville L. & Luke A. Miles. (1997). Arrhenius parameters for the reaction of H atoms with SiH4. Journal of the Chemical Society Faraday Transactions. 93(24). 4259–4264. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven Lynham Breakdown of academic impact, for papers by James F. LeBlanc Breakdown of academic impact, for papers by David A. Middleton Breakdown of academic impact, for papers by Jeffrey Hanson Breakdown of academic impact, for papers by Guowei Yin Breakdown of academic impact, for papers by Stefan W. Vetter Breakdown of academic impact, for papers by Steven A. Rich Breakdown of academic impact, for papers by Francesco Ravotti Breakdown of academic impact, for papers by Christian Haupt Breakdown of academic impact, for papers by Young‐Sang Jung
Rankless by CCL
2026